How Will DuPont (DD) Stock Be Affected by Cancer Case Ruling?

An Ohio jury ruled today on punitive damages owed to a man who developed cancer from DuPont's (DD) toxic chemicals in drinking water.
By Rachel Aldrich ,

NEW YORK ( TheStreet) --  DuPont (DD) - Get Report  owes $500,000 to a man in a cancer lawsuit after an Ohio court assigned punitive damages today.

Lawyers debated Thursday  as to whether the company should pay as much as $1.2 billion in punitive damages, Bloomberg reports. The damages assigned are far less than expected.

DuPont was sued after the company allegedly leaked Teflon C-8 toxin into the Ohio River at a West Virginia plant. One man developed testicular cancer from drinking water contaminated by the chemical.

The jury awarded the defendant $5.1 million in damages on Wednesday afternoon, making the total owed by DuPont $5.6 million.

This is the third case DuPont has lost involving this toxin.

Shares of DuPont, a Wilmington, DE-based science and technology company, rose by 2.68% to $63.58 in afternoon trade.

Separately, TheStreet Ratings rated this stock as a "buy" with a ratings score of B+.

The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and growth in earnings per share.

TheStreet Ratings feels its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

You can view the full analysis from the report here: DD

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. 

Loading ...